Cardiovascular Risk Factor Management Performance in Canada and the United States: A Systematic Review

Canadian Journal of Cardiology

Volumn 33, Issue 3, 2017, Pages 393-404

  Alabousi, Mostafa ^a   Abdullah, Peri ^b   Alter, David A ^c,d,e   Booth, Gillian L ^d,e,f   Hogg, William ^a,d,g,h   Ko, Dennis T ^d,e,i   Manuel, Douglas G ^g,h   Farkouh, Michael E ^e,j   Tu, Jack V ^d,e,i   Udell, Jacob A ^d,e,j,k  

^a UNIVERSITY OF OTTAWA   (Canada)

^b YORK UNIVERSITY   (Canada)

^c TORONTO REHABILITATION INSTITUTE   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^h BRUYÈRE RESEARCH INSTITUTE   (Canada)

ⁱ SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^j UNIVERSITY HEALTH NETWORK   (Canada)

^k WOMEN S COLLEGE HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

AWARENESS; BLOOD GLUCOSE MONITORING; CANADA; CARDIOVASCULAR RISK; DIABETES CONTROL; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; HYPERTENSION; META ANALYSIS; NORTH AMERICA; PATIENT COUNSELING; PRACTICE GUIDELINE; REVIEW; SCREENING; SMOKING; SYSTEMATIC REVIEW; TOBACCO USE; UNITED STATES; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; MORBIDITY; RISK FACTOR; TRENDS;

CANADA; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; HUMANS; MORBIDITY; RISK FACTORS; UNITED STATES;

EID: 85006999174     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2016.07.005     Document Type: Review

References (159)

1. 1 Patel, S.A., Winkel, M., Ali, M.K., Narayan, K.M., Mehta, N.K., Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med 163 (2015), 245–253.
2. 2 Turnbull, F., Neal, B., Ninomiya, T., et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 336 (2008), 1121–1123.
3. 3 Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002), 7–22.
4. 4 Holman, R.R., Paul, S.K., Bethel, M.A., Matthews, D.R., Neil, H.A., 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008), 1577–1589.
5. 5 Mons, U., Müezzinler, A., Gellert, C., et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ, 350, 2015, h1551.
6. 6 American Diabetes Association, (8) Cardiovascular disease and risk management. Diabetes Care 38:suppl (2015), S49–S57.
7. 7 Goff, D.C., Lloyd-Jones, D.M., Bennett, G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2935–2959.
8. 8 Pearson, T.A., Blair, S.N., Daniels, S.R., et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106 (2002), 388–391.
9. 9 Daskalopoulou, S.S., Rabi, D.M., Zarnke, K.B., et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 31 (2015), 549–568.
10. 10 James, P.A., Oparil, S., Carter, B.L., et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311 (2014), 507–520.
11. 11 Anderson, T.J., Grégoire, J., Hegele, R.A., et al. 2012 Update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 29 (2013), 151–167.
12. 12 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002), 3143–3421.
13. 13 Stone, N.J., Robinson, J.G., Lichtenstein, A.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:25 suppl 2 (2014), S1–S45.
14. 14 Buse, J.B., Ginsberg, H.N., Bakris, G.L., et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 115 (2007), 114–126.
15. 15 Booth, G., Cheng, A.Y., Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Methods. Can J Diabetes 37:suppl 1 (2013), S4–S7.
16. 16 Pipe, A.L., Eisenberg, M.J., Gupta, A., et al. Smoking cessation and the cardiovascular specialist: Canadian Cardiovascular Society position paper. Can J Cardiol 27 (2011), 132–137.
17. 17 West, R., McNeill, A., Raw, M., Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 55 (2000), 987–999.
18. 18 Arnett, D.K., Goodman, R.A., Halperin, J.L., et al. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services. Circulation 130 (2014), 1662–1667.
19. 19 Mosca, L., Linfante, A.H., Benjamin, E.J., et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 111 (2005), 499–510.
20. 20 Tu, J.V., Chu, A., Donovan, L.R., et al. The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services. Circ Cardiovasc Qual Outcomes 8 (2015), 204–212.
21. 21 Norris, T.E., Schaad, D.C., DeWitt, D., et al. Longitudinal integrated clerkships for medical students: an innovation adopted by medical schools in Australia, Canada, South Africa, and the United States. Acad Med 84 (2009), 902–907.
22. 22 Blumenthal, D., Abrams, M., Nuzum, R., The Affordable Care Act at 5 Years. N Engl J Med, 373, 2015, 1580.
23. 23 LaPierre, T.A., Comparing the Canadian and US systems of health care in an era of health care reform. J Health Care Finance 38 (2012), 1–18.
24. 24 Stroup, D.F., Berlin, J.A., Morton, S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000), 2008–2012.
25. 25 Maciosek, M.V., Coffield, A.B., Edwards, N.M., et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 31 (2006), 52–61.
26. 26 Farley, T.A., Dalal, M.A., Mostashari, F., Frieden, T.R., Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med 38 (2010), 600–609.
27. 27 Leenen, F.H., Dumais, J., McInnis, N.H., et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 178 (2008), 1441–1449.
28. 28 McAlister, F.A., Wilkins, K., Joffres, M., et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 183 (2011), 1007–1013.
29. 29 Petrella, R.J., Merikle, E.P., Jones, J., Prevalence, treatment, and control of hypertension in primary care: gaps, trends, and opportunities. J Clin Hypertens (Greenwich) 9 (2007), 28–35.
30. 30 Chow, C.K., Teo, K.K., Rangarajan, S., et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310 (2013), 959–968.
31. 31 Gee, M.E., Bienek, A., McAlister, F.A., et al. Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension. Can J Cardiol 28 (2012), 375–382.
32. 32 Joffres, M., Falaschetti, E., Gillespie, C., et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open, 3, 2013, e003423.
33. 33 Julien, C.T., Prevalence, awareness, treatment and control of hypertension and associated risk factors within the pure-Quebec cohort. J Pharm Pharm Sci 14 (2011), 93s–94s.
34. 34 Wilkins, K.C., Blood pressure in Canadian adults. Health Rep 21 (2010), 37–46.
35. 35 Joffres, M.R., Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 14 (2001), 1099–1105.
36. 36 Blais, C., Rochette, L., Hamel, D., Poirier, P., Prevalence, incidence, awareness, and control of hypertension in the province of Quebec: perspective from administrative and survey data. Can J Public Health 105 (2014), 79–85.
37. 37 Gee, M.E., Campbell, N.R., Gwadry-Sridhar, F., et al. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension. Can J Cardiol 28 (2012), 383–389.
38. 38 Campbell, N.R., So, L., Amankwah, E., Quan, H., Maxwell, C., Characteristics of hypertensive Canadians not receiving drug therapy. Can J Cardiol 24 (2008), 485–490.
39. 39 Khan, N., Chockalingam, A., Campbell, N.R., Lack of control of high blood pressure and treatment recommendations in Canada. Can J Cardiol 18 (2002), 657–661.
40. 40 Onysko, J., Maxwell, C., Eliasziw, M., et al. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension 48 (2006), 853–860.
41. 41 Antikainen, R.L., Moltchanov, V.A., Chukwuma, C., et al. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil 13 (2006), 13–29.
42. 42 Padwal, R.S., Bienek, A., McAlister, F.A., Campbell, N.R., Outcomes Research Task Force of the Canadian Hypertension Education Program. Epidemiology of hypertension in Canada: an update. Can J Cardiol 32 (2016), 687–694.
43. 43 Wolf-Maier, K., Cooper, R.S., Banegas, J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289 (2003), 2363–2369.
44. 44 Wolf-Maier, K., Cooper, R.S., Kramer, H., et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43 (2004), 10–17.
45. 45 Borkhoff, C.M., Saskin, R., Rabeneck, L., et al. Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods. Can J Public Health 104 (2013), e284–e290.
46. 46 Joffres, M., Shields, M., Tremblay, M.S., Connor, G.S., Dyslipidemia prevalence, treatment, control, and awareness in the Canadian Health Measures Survey. Can J Public Health 104 (2013), e252–e257.
47. 47 Lugomirski, P., Guo, H., Boom, N.K., et al. Quality of diabetes and hyperlipidemia screening before a first myocardial infarction. Can J Cardiol 29 (2013), 1382–1387.
48. 48 Lugomirski, P.G., Quality of preventive care prior to a first myocardial infarction. Can J Cardiol, 59, 2012, S184.
49. 49 Tolonen, H.K., Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA project. Int J Epidemiol 34 (2005), 181–192.
50. 50 Creatore, M.I., Booth, G.L., Manuel, D.G., Moineddin, R., Glazier, R.H., Diabetes screening among immigrants: a population-based urban cohort study. Diabetes Care 35 (2012), 754–761.
51. 51 Harris, S.B., Diabetes management in Canada: baseline results of the group practice diabetes management study. Can J Diabetes 30 (2006), 131–137.
52. 52 Leiter, L.A., Barr, A., Belanger, A., et al. Diabetes Screening in Canada (DIASCAN) study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices. Diabetes Care 24 (2001), 1038–1043.
53. 53 Robinson, C., Abdel-Motagally, M., Morrison, H., Shi, Y., Vardy, L., Effective uptake of screening blood-tests for diabetes in Canada. Can J Diabetes, 33, 2009, 282.
54. 54 Wilson, S.E., Lipscombe, L.L., Rosella, L.C., Manuel, D.G., Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study. BMC Health Serv Res, 9, 2009, 41.
55. 55 Wilson, S.E., Rosella, L.C., Lipscombe, L.L., Manuel, D.G., The effectiveness and efficiency of diabetes screening in Ontario, Canada: a population-based cohort study. BMC Public Health, 10, 2010, 506.
56. 56 Centers for Disease Control and Prevention (CDC), Racial/ethnic disparities in prevalence, treatment, and control of hypertension–United States, 1999-2002. MMWR Morb Mortal Wkly Rep 54 (2005), 7–9.
57. 57 Cheung, B.M., Ong, K.L., Man, Y.B., Lam, K.S., Lau, C.P., Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens (Greenwich) 8 (2006), 93–98.
58. 58 Cohen, J.D., Cziraky, M.J., Cai, Q., et al. 30-Year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006. Am J Cardiol 106 (2010), 969–975.
59. 59 Cutler, J.A., Sorlie, P.D., Wolz, M., et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 52 (2008), 818–827.
60. 60 Egan, B.M., Zhao, Y., Axon, R.N., US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303 (2010), 2043–2050.
61. 61 Egan, B.M., Hypertension in the U.S. 1988-2008: Pursuit of the Healthy People 2010 blood pressure control goal. J Clin Hypertens 12 (2010), 246–252.
62. 62 Centers for Disease Control and Prevention (CDC), Vital signs: Prevalence, treatment, and control of hypertension — United States, 1999–2002 and 2005–2008. MMWR Morb Mortal Wkly Rep 60 (2011), 103–108.
63. 63 Gu, Q., Burt, V.L., Paulose-Ram, R., Dillon, C.F., Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Am J Hypertens 21 (2008), 789–798.
64. 64 Gu, Q., Paulose-Ram, R., Dillon, C., Burt, V., Antihypertensive medication use among US adults with hypertension. Circulation 113 (2006), 213–221.
65. 65 Guo, F., He, D., Zhang, W., Walton, R.G., Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 60 (2012), 599–606.
66. 66 Hajjar, I., Kotchen, T.A., Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003), 199–206.
67. 67 Hayes, D.K., Denny, C.H., Keenan, N.L., Croft, J.B., Greenlund, K.J., Health-related quality of life and hypertension status, awareness, treatment, and control: National Health and Nutrition Examination Survey, 2001-2004. J Hypertens 26 (2008), 641–647.
68. 68 Hyman, D.J., Pavlik, V.N., Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 345 (2001), 479–486.
69. 69 Olives, C., Myerson, R., Mokdad, A.H., Murray, C.J., Lim, S.S., Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009. PLoS One, 8, 2013, e60308.
70. 70 Ong, K.L., Cheung, B.M., Man, Y.B., Lau, C.P., Lam, K.S., Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49 (2007), 69–75.
71. 71 Ostchega, Y., Hughes, J.P., Wright, J.D., McDowell, M.A., Louis, T., Are demographic characteristics, health care access and utilization, and comorbid conditions associated with hypertension among US adults?. Am J Hypertens 21 (2008), 159–165.
72. 72 Ostchega, Y., Yoon, S.S., Hughes, J., Louis, T., Hypertension awareness, treatment, and control–continued disparities in adults: United States, 2005-2006. NCHS Data Brief, 2008, 1–8.
73. 73 Qureshi, A.I., Suri, M.F., Kirmani, J.F., Divani, A.A., Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit 11 (2005), CR403–CR409.
74. 74 Valderrama, A.L., Vital signs: awareness and treatment of uncontrolled hypertension among adults - United States, 2003-2010. MMWR Morb Mortal Wkly Rep 61 (2012), 703–709.
75. 75 Whelton, P.K., He, J., Muntner, P., Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens 18 (2004), 545–551.
76. 76 Wong, N.D., Dede, J., Chow, V.H., Wong, K.S., Franklin, S.S., Global cardiovascular risk associated with hypertension and extent of treatment and control according to risk group. Am J Hypertens 25 (2012), 561–567.
77. 77 Yoon, S.S., Ostchega, Y., Louis, T., Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008. NCHS Data Brief, 2010, 1–8.
78. 78 Yoon, S.S., Hypertension among adults in the United States, 2009-2010. NCHS Data Brief, 2012, 1–8.
79. 79 Ostchega, Y.S., Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008. Hypertension, 48, 2010, e65.
80. 80 Centers for Disease Control and Prevention (CDC), State-specific trends in self-reported blood pressure screening and high blood pressure–United States, 1991-1999. MMWR Morb Mortal Wkly Rep 51 (2002), 456–460.
81. 81 Centers for Disease Control and Prevention (CDC), Self-reported hypertension and use of antihypertensive medication among adults – United States, 2005-2009. MMWR Morb Mortal Wkly Rep, 62, 2013, 8.
82. 82 Jiles, R., Hughes, E., Murphy, W., et al. Surveillance for certain health behaviors among states and selected local areas–Behavioral Risk Factor Surveillance System, United States, 2003. MMWR Surveill Summ 54 (2005), 1–116.
83. 83 Natarajan, S., Nietert, P.J., National trends in screening, prevalence, and treatment of cardiovascular risk factors. Prev Med 36 (2003), 389–397.
84. 84 Cherry, D.K., Woodwell, D.A., National Ambulatory Medical Care Survey: 2000 summary. Adv Data, 2002, 1–32.
85. 85 Keyhani, S., Scobie, J.V., Hebert, P.L., McLaughlin, M.A., Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension 51 (2008), 1149–1155.
86. 86 Ma, J., Stafford, R.S., Screening, treatment, and control of hypertension in US private physician offices, 2003-2004. Hypertension 51 (2008), 1275–1281.
87. 87 Allen, N.B., Diez-Roux, A., Liu, K., et al. Association of health professional shortage areas and cardiovascular risk factor prevalence, awareness, and control in the Multi-Ethnic Study of Atherosclerosis (MESA). Circ Cardiovasc Qual Outcomes 4 (2011), 565–572.
88. 88 Murasko, J.E., Gender differences in the management of risk factors for cardiovascular disease: the importance of insurance status. Soc Sci Med 63 (2006), 1745–1756.
89. 89 Arnett, D.K., McGovern, P.G., Jacobs, D.R., et al. Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey. Am J Epidemiol 156 (2002), 929–935.
90. 90 Luepker, R.V., Arnett, D.K., Jacobs, D.R., et al. Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey. Am J Med 119 (2006), 42–49.
91. 91 Luepker, R.V., Steffen, L.M., Jacobs, D.R. Jr., Zhou, X., Blackburn, H., Trends in blood pressure and hypertension detection, treatment, and control 1980 to 2009: the Minnesota Heart Survey. Circulation 126 (2012), 1852–1857.
92. 92 Belletti, D.A., Hypertension treatment and control among 28 physician practices across the US: results of the Hypertension: Assessment of Treatment to Target (HATT) study. J Clin Hypertens 11(suppl 1) (2009), A141–A142.
93. 93 Dickson, B.K., Blackledge, J., Hajjar, I.M., The impact of lifestyle behavior on hypertension awareness, treatment, and control in a southeastern population. Am J Med Sci 332 (2006), 211–215.
94. 94 Wang, Y.R., Alexander, G.C., Stafford, R.S., Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 167 (2007), 141–147.
95. 95 Centers for Disease Control and Prevention (CDC), Disparities in screening for and awareness of high blood cholesterol–United States, 1999-2002. MMWR Morb Mortal Wkly Rep 54 (2005), 117–119.
96. 96 Centers for Disease Control and Prevention (CDC), Vital signs: Prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol — United States, 1999–2002 and 2005–2008. MMWR Morb Mortal Wkly Rep 60 (2011), 109–114.
97. 97 Carroll, M.D., Kit, B.K., Lacher, D.A., Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2009-2010. NCHS Data Brief, 2012, 1–8.
98. 98 Carroll, M.D., Kit, B.K., Lacher, D.A., Shero, S.T., Mussolino, M.E., Trends in lipids and lipoproteins in US adults, 1988-2010. JAMA 308 (2012), 1545–1554.
99. 99 Christian, J.B., Bourgeois, N.E., Lowe, K.A., Cholesterol screening in US adults and awareness of high cholesterol among individuals with severe hypertriglyceridemia: National Health and Nutrition Examination Surveys 2001-2008. J Cardiovasc Nurs 30 (2015), 26–34.
100. 100 Ford, E.S., Mokdad, A.H., Giles, W.H., Mensah, G.A., Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 107 (2003), 2185–2189.
101. 101 Gillespie, C.D., Keenan, N.L., Miner, J.B., Hong, Y., Screening for lipid disorders among adults–National Health and Nutrition Examination Survey, United States, 2005-2008. MMWR Suppl 61 (2012), 26–31.
102. 102 Hyre, A.D., Muntner, P., Menke, A., Raggi, P., He, J., Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol 17 (2007), 548–555.
103. 103 Kuklina, E.V., Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA 302 (2009), 2104–2110.
104. 104 Merkin, S.S., Karlamangla, A., Crimmins, E., et al. Education differentials by race and ethnicity in the diagnosis and management of hypercholesterolemia: a national sample of U.S. adults (NHANES 1999-2002). Int J Public Health 54 (2009), 166–174.
105. 105 Muntner, P., DeSalvo, K.B., Wildman, R.P., et al. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol 163 (2006), 913–920.
106. 106 Muntner, P., Levitan, E.B., Brown, T.M., et al. Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010. Am J Cardiol 112 (2013), 664–670.
107. 107 Muntner, P.L., Trends in high LDL-cholesterol prevalence, awareness, treatment and control among us adults [abstract 15587]. Circulation, 126(suppl 21):A15587, 2012.
108. 108 Pahuja, S., Lu, K., Trends in prevalence, awareness, treatment, and control of hyperlipidemia among the United States adults: 2001-2010 [abstract PCV32]. Value Health, 16, 2013, A277.
109. 109 Centers for Disease Control and Prevention (CDC), State-specific cholesterol screening trends–United States, 1991-1999. MMWR Morb Mortal Wkly Rep 49 (2000), 750–755.
110. 110 Centers for Disease Control and Prevention (CDC), State-specific trends in high blood cholesterol awareness among persons screened–United States, 1991-1999. MMWR Morb Mortal Wkly Rep 50 (2001), 754–758.
111. 111 Centers for Disease Control and Prevention (CDC), Trends in cholesterol screening and awareness of high blood cholesterol–United States, 1991-2003. MMWR Morb Mortal Wkly Rep 54 (2005), 865–870.
112. 112 Centers for Disease Control and Prevention (CDC), Prevalence of cholesterol screening and high blood cholesterol among adults–United States, 2005, 2007, and 2009. MMWR Morb Mortal Wkly Rep 61 (2012), 697–702.
113. 113 Brown, D.W., Giles, W.H., Greenlund, K.J., Croft, J.B., Disparities in cholesterol screening: falling short of a national health objective. Prev Med 33 (2001), 517–522.
114. 114 Chowdhury, P., Balluz, L., Town, M., et al. Surveillance of certain health behaviors and conditions among states and selected local areas - Behavioral Risk Factor Surveillance System, United States, 2007. MMWR Surveill Summ 59 (2010), 1–220.
115. 115 Chowdhury, P.P., Balluz, L., Murphy, W., et al. Surveillance of certain health behaviors among states and selected local areas–United States, 2005. MMWR Surveill Summ 56 (2007), 1–160.
116. 116 Goff, D.C. Jr., Bertoni, A.G., Kramer, H., et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113 (2006), 647–656.
117. 117 Li, C., Balluz, L.S., Okoro, C.A., et al. Surveillance of certain health behaviors and conditions among states and selected local areas — Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ 60 (2011), 1–250.
118. 118 Kiefer, M.M., Silverman, J.B., Young, B.A., Nelson, K.M., National patterns in diabetes screening: data from the National Health and Nutrition Examination Survey (NHANES) 2005-2012. J Gen Intern Med 30 (2015), 612–618.
119. 119 Koro, C.E., Bowlin, S.J., Bourgeois, N., Fedder, D.O., Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 27 (2004), 17–20.
120. 120 Lu, K.Y., Trends in prevalence, awareness, treatment, and control of diabetes in the United States, 1999-2010 [abstract PDB20]. Value Health, 16, 2013, A159.
121. 121 McWilliams, J.M., Meara, E., Zaslavsky, A.M., Ayanian, J.Z., Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of Medicare coverage. Ann Intern Med 150 (2009), 505–515.
122. 122 Ong, K.L., Cheung, B.M., Wong, L.Y., et al. Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol 18 (2008), 222–229.
123. 123 Ong, K.L., Treatment and control of diabetes mellitus in the United States National Health and Nutrition Examination Survey, 1999-2002. J Cardiometab Syndr 1 (2006), 301–307.
124. 124 Selvin, E., Parrinello, C.M., Sacks, D.B., Coresh, J., Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med 160 (2014), 517–525.
125. 125 Annunziata, K.S., Changes in patient characteristics and treatment patterns among patients with type 2 diabetes in the United States from 2006-2013 [abstract PDB23]. Value Health, 17, 2014, A241.
126. 126 Bergenstal, R.M., Nag, S.S., Reusch, J.E., Sajjan, S.G., Alexander, C.M., Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control. Endocr Pract 11 (2005), 172–179.
127. 127 Sonnenfeld, N., Schappert, S.M., Lin, S.X., Racial and ethnic differences in delivery of tobacco-cessation services. Am J Prev Med 36 (2009), 21–28.
128. 128 Steinberg, M.B., Akincigil, A., Delnevo, C.D., Crystal, S., Carson, J.L., Gender and age disparities for smoking-cessation treatment. Am J Prev Med 30 (2006), 405–412.
129. 129 Thorndike, A.N., The treatment of smoking by US physicians during ambulatory visits: 1994-2003. Am J Public Health 97 (2007), 1878–1883.
130. 130 Wallace, A.E., Tobacco cessation counseling across the ages. J Am Geriatr Soc 54 (2006), 1425–1428.
131. 131 Centers for Disease Control and Prevention (CDC), Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morb Mortal Wkly Rep 58 (2009), 1227–1232.
132. 132 Centers for Disease Control and Prevention (CDC), Quitting smoking among adults–United States, 2001-2010. MMWR Morb Mortal Wkly Rep 60 (2011), 1513–1519.
133. 133 Denny, C.H., Serdula, M.K., Holtzman, D., Nelson, D.E., Physician advice about smoking and drinking: are U.S. adults being informed?. Am J Prev Med 24 (2003), 71–74.
134. 134 Houston, T.K., Patient smoking cessation advice by health care providers: the role of ethnicity, socioeconomic status, and health. Am J Public Health 95 (2005), 1056–1061.
135. 135 Kruger, J.S., Health care providers' advice to quit smoking, National Health Interview Survey, 2000, 2005, and 2010. Prev Chronic Dis, 9, 2012, E130.
136. 136 Lucan, S.C., Katz, D.L., Factors associated with smoking cessation counseling at clinical encounters: the Behavioral Risk Factor Surveillance System (BRFSS) 2000. Am J Health Promot 21 (2006), 16–23.
137. 137 Nelson, D.E., Bland, S., Powell-Griner, E., et al. State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s. JAMA 287 (2002), 2659–2667.
138. 138 Marbella, A.M., Riemer, A., Remington, P., Guse, C.E., Layde, P.M., Wisconsin physicians advising smokers to quit: results from the Current Population Survey, 1998-1999 and Behavioral Risk Factor Surveillance System, 2000. WMJ 102 (2003), 41–45.
139. 139 Rosen, B., Porath, A., Pawlson, L.G., Chassin, M.R., Benbassat, J., Adherence to standards of care by health maintenance organizations in Israel and the USA. Int J Qual Health Care 23 (2011), 15–25.
140. 140 Centers for Disease Control and Prevention (CDC), Tobacco use among adults–Arizona, 1996 and 1999. MMWR Morb Mortal Wkly Rep 50 (2001), 402–406.
141. 141 Doescher, M.P., Saver, B.G., Physicians' advice to quit smoking. The glass remains half empty. J Fam Pract 49 (2000), 543–547.
142. 142 Quinn, V.P., Stevens, V.J., Hollis, J.F., et al. Tobacco-cessation services and patient satisfaction in nine nonprofit HMOs. Am J Prev Med 29 (2005), 77–84.
143. 143 Reed, M.B., A population-based examination of racial and ethnic differences in receiving physicians' advice to quit smoking. Nicotine Tob Res 10 (2008), 1487–1494.
144. 144 Smith, S.S., Health care provider use of guideline-based smoking cessation interventions: results from the 2003 Wisconsin Tobacco Survey. WMJ 104 (2005), 28–31.
145. 145 Nwankwo, T., Yoon, S.S., Burt, V., Gu, Q., Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief 133 (2013), 1–8.
146. 146 Arnett, D.K., Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation 112 (2005), 3884–3891.
147. 147 Barham, A.H., Goff, D.C. Jr., Chen, H., et al. Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk. Prev Cardiol 12 (2009), 95–101.
148. 148 Bertoni, A.G., Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina. Am Heart J 152 (2006), 785–792.
149. 149 Pearson, T.A., Laurora, I., Chu, H., Kafonek, S., The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 160 (2000), 459–467.
150. 150 Rifas-Shiman, S.L., Forman, J.P., Lane, K., Caspard, H., Gillman, M.W., Diabetes and lipid screening among patients in primary care: a cohort study. BMC Health Serv Res, 8, 2008, 25.
151. 151 Ealovega, M.W., Tabaei, B.P., Brandle, M., Burke, R., Herman, W.H., Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 27 (2004), 9–12.
152. 152 Straka, R.J., Taheri, R., Cooper, S.L., Tan, A.W., Smith, A.C., Assessment of hypercholesterolemia control in a managed care organization. Pharmacotherapy 21 (2001), 818–827.
153. 153 Reid, J.L., Hammond, D., Rynard, V.L., Burkhalter, R., Tobacco Use in Canada: Patterns and Trends, 2015 Edition. 2015, Propel Centre for Population Health Impact, University of Waterloo, Waterloo, Ontario.
154. 154 Grundy, S.M., Cleeman, J.I., Merz, C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004), 227–239.
155. 155 American Diabetes Association, Standards of medical care in diabetes–2014. Diabetes Care 37:suppl 1 (2014), S14–S80.
156. 156 Campbell, N.R., McAlister, F.A., Brant, R., et al. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens 21 (2003), 1591–1597.
157. 157 Jackson, J.H., Sobolski, J., Krienke, R., et al. Blood pressure control and pharmacotherapy patterns in the United States before and after the release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines. J Am Board Fam Med 21 (2008), 512–521.
158. 158 Mann, D., Reynolds, K., Smith, D., Muntner, P., Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother 42 (2008), 1208–1215.
159. 159 Myers, M.G., Tobe, S.W., A Canadian perspective on the Eighth Joint National Committee (JNC 8) hypertension guidelines. J Clin Hypertens (Greenwich) 16 (2014), 246–248.